Kirk R. Daffner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kirk R. Daffner has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Erich S. Tusch
CHIP Copenhagen University Hospital—Rigshospitalet Copenhagen Denmark
3 shared publications Seth A. Gale
Departments of Neurology (Gettens Bourgea, Erkkinen, Gale, McGinnis, Daffner) and Psychiatry (Silbersweig, Schildkrout), Center for Brain/Mind Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston
3 shared publicationsAbdul H. Mohammed
Department of Psychology Linnaeus University Växjö Sweden
2 shared publicationsBrittany M. McFeeley
Laboratory of Healthy Cognitive Aging Center for Brain/Mind Medicine Department of Neurology Harvard Medical School Brigham and Women's Hospital Boston Massachusetts USA
2 shared publications- Brittany M. McFeeley
Center for Brain/Mind Medicine, Laboratory of Healthy Cognitive Aging, Department of Neurology, Brigham and Women's Hospital/Harvard Medical School, 60 Fenwood Road, Boston, MA, 02115, USA
2 shared publications Casey M. Nicastri
Laboratory of Healthy Cognitive Aging Center for Brain/Mind Medicine Department of Neurology Harvard Medical School Brigham and Women's Hospital Boston Massachusetts USA
2 shared publications
Latest Publications
- Open Access
- 10 July 2026
- Published by Elsevier in The Journal Of Prevention of Alzheimer's Disease
- Vol. 13 (8) , 100640
Suboptimal adherence to brain health recommendations in patients pursuing anti-amyloid antibody therapy for Alzheimer’s disease: Report from the Brain Health Vital Signs project
- 10 July 2026
- Published by Elsevier in The Journal Of Prevention of Alzheimer's Disease
- Vol. 13 (8) , 100640
Open AccessSuboptimal adherence to brain health recommendations in patients pursuing anti-amyloid antibody therapy for Alzheimer’s disease: Report from the Brain Health Vital Signs project
- Open Access
- 25 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S4) , e106775
How well do patients pursuing anti‐amyloid antibody therapies for Alzheimer's disease adhere to guidelines for promoting brain health?
Background: Patients seeking anti‐amyloid antibody therapies (AATs) are prepared to invest considerable time and effort to slow the progression of AD. How well these highly motivated patients follow consensus guidelines regarding modifiable risk factors for cognitive decline and dementia remains to be determined. Method: 101 patients with MCI ( n = 63) or mild dementia ( n = 38) due to AD (mean age=74; 54% female), being evaluated for AATs were assessed on 15 modifiable risk factors by questionnaire and review of electronic medical record (EMR) data. The 15 factors included physical activity, cognitive activity, social engagement, mood, hearing, LDL cholesterol level, and HbA1c, among others. Scores (0‐2) for each factor reflected degree of adherence to recommended guidelines: 0=not met; 1=partially met/room for growth; 2=optimally met; maximum score=30 for overall adherence to brain health recommendations. Result: For 7 factors, 3 38% of patients were not optimally following brain health guidelines: blood pressure (44%), HbA1c (59%), BMI (58%), physical activity (64%), LDL (41%), mood (53%), and cognitive activity (38%). For 4 factors, 64‐73% of patients were optimally following guidelines: sleep (64%), hearing (65%), diet (72%), and social engagement (73%). For 4 factors, >80% were optimally following guidelines: smoking (99%), alcohol (88%), vision (90%), and finding purpose in life (81%). Numerically, MCI patients exhibited slightly higher adherence scores than patients with mild dementia ( p = 0.1). No recent data (within 1.5 years) were found in the EMR for LDL in 27% of patients and for HbA1c in 45% of patients. Conclusion: A mix of pharmacologic and lifestyle interventions will likely result in the best outcomes in AD. In this sample of very motivated AD patients pursuing AATs, a sizeable portion were not fully adhering to brain health guidelines for reducing risk of cognitive decline. Many of the factors not optimally followed are also recommended for vascular health. These results highlight a critical gap in enhancing care for patients with underlying AD. Healthcare systems must establish more effective strategies and concrete interventions for addressing modifiable risk factors. Moreover, better systems are needed to ensure relevant, actionable patient data related to brain health (e.g., HbA1c, LDL) are collected and updated in the EMR.
- 25 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S4) , e106775
Open AccessHow well do patients pursuing anti‐amyloid antibody therapies for Alzheimer's disease adhere to guidelines for promoting brain health?
Background: Patients seeking anti‐amyloid antibody therapies (AATs) are prepared to invest considerable time and effort to slow the progression of AD. How well these highly motivated patients follow consensus guidelines regarding modifiable risk factors for cognitive decline and dementia remains to be determined. Method: 101 patients with MCI ( n = 63) or mild dementia ( n = 38) due to AD (mean age=74; 54% female), being evaluated for AATs were assessed on 15 modifiable risk factors by questionnaire and review of electronic medical record (EMR) data. The 15 factors included physical activity, cognitive activity, social engagement, mood, hearing, LDL cholesterol level, and HbA1c, among others. Scores (0‐2) for each factor reflected degree of adherence to recommended guidelines: 0=not met; 1=partially met/room for growth; 2=optimally met; maximum score=30 for overall adherence to brain health recommendations. Result: For 7 factors, 3 38% of patients were not optimally following brain health guidelines: blood pressure (44%), HbA1c (59%), BMI (58%), physical activity (64%), LDL (41%), mood (53%), and cognitive activity (38%). For 4 factors, 64‐73% of patients were optimally following guidelines: sleep (64%), hearing (65%), diet (72%), and social engagement (73%). For 4 factors, >80% were optimally following guidelines: smoking (99%), alcohol (88%), vision (90%), and finding purpose in life (81%). Numerically, MCI patients exhibited slightly higher adherence scores than patients with mild dementia ( p = 0.1). No recent data (within 1.5 years) were found in the EMR for LDL in 27% of patients and for HbA1c in 45% of patients. Conclusion: A mix of pharmacologic and lifestyle interventions will likely result in the best outcomes in AD. In this sample of very motivated AD patients pursuing AATs, a sizeable portion were not fully adhering to brain health guidelines for reducing risk of cognitive decline. Many of the factors not optimally followed are also recommended for vascular health. These results highlight a critical gap in enhancing care for patients with underlying AD. Healthcare systems must establish more effective strategies and concrete interventions for addressing modifiable risk factors. Moreover, better systems are needed to ensure relevant, actionable patient data related to brain health (e.g., HbA1c, LDL) are collected and updated in the EMR.
- 1 October 2024
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 81 (10) , 1021-1022
It Is Time for Medicare to Cover Driving Safety Assessments
This Viewpoint advocates for Medicare coverage of driving assessments for older individuals.
- 1 October 2024
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 81 (10) , 1021-1022
It Is Time for Medicare to Cover Driving Safety Assessments
This Viewpoint advocates for Medicare coverage of driving assessments for older individuals.
- Open Access
- 30 August 2022
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 8 (1) , e12337
BDNF mediates improvement in cognitive performance after computerized cognitive training in healthy older adults
Introduction: The often‐cited mechanism linking brain‐derived neurotrophic factor (BDNF) to cognitive health has received limited experimental study. There is evidence that cognitive training, physical exercise, and mindfulness meditation may improve cognition. Here, we investigated whether improvements in cognition after these three types of structured interventions are facilitated by increases in BDNF. Methods: A total of 144 heathy older adults completed a 5‐week intervention involving working memory/cognitive training, physical exercise, mindfulness meditation, or an active control condition. Serum BDNF levels and Digit Symbol Test (DST) performance were measured pre‐ and post‐intervention. Results: Linear mixed models suggested that only the cognitive training group demonstrated augmentation of BDNF and DST performance relative to the control condition. Path analysis revealed that changes in BDNF mediate intervention‐related improvement in task performance. Regression analyses showed that, across all intervention conditions, increased BDNF levels were associated with increased DST scores. Discussion: This study appears to be the first to suggest that BDNF helps mediate improvements in cognition after working memory training in healthy older adults. Highlights: Older adults were randomized to physical activity, mindfulness, cognitive training (computerized cognitive training (CCT), or control. CCT, but no other condition, led to increased serum brain‐derived neurotrophic factor (BDNF) levels. CCT led to improvement on the untrained Digit Symbol Test (DST) of speed/working memory. Path analysis: increases in BDNF mediate intervention‐related improvement on DST. Increases in BDNF associated with improved DST across all experimental groups.
- 30 August 2022
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 8 (1) , e12337
Open AccessBDNF mediates improvement in cognitive performance after computerized cognitive training in healthy older adults
Introduction: The often‐cited mechanism linking brain‐derived neurotrophic factor (BDNF) to cognitive health has received limited experimental study. There is evidence that cognitive training, physical exercise, and mindfulness meditation may improve cognition. Here, we investigated whether improvements in cognition after these three types of structured interventions are facilitated by increases in BDNF. Methods: A total of 144 heathy older adults completed a 5‐week intervention involving working memory/cognitive training, physical exercise, mindfulness meditation, or an active control condition. Serum BDNF levels and Digit Symbol Test (DST) performance were measured pre‐ and post‐intervention. Results: Linear mixed models suggested that only the cognitive training group demonstrated augmentation of BDNF and DST performance relative to the control condition. Path analysis revealed that changes in BDNF mediate intervention‐related improvement in task performance. Regression analyses showed that, across all intervention conditions, increased BDNF levels were associated with increased DST scores. Discussion: This study appears to be the first to suggest that BDNF helps mediate improvements in cognition after working memory training in healthy older adults. Highlights: Older adults were randomized to physical activity, mindfulness, cognitive training (computerized cognitive training (CCT), or control. CCT, but no other condition, led to increased serum brain‐derived neurotrophic factor (BDNF) levels. CCT led to improvement on the untrained Digit Symbol Test (DST) of speed/working memory. Path analysis: increases in BDNF mediate intervention‐related improvement on DST. Increases in BDNF associated with improved DST across all experimental groups.
- Open Access
- 21 April 2021
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 81 (3) , 871-920
Promoting Successful Cognitive Aging: A Ten-Year Update
A decade has passed since we published a comprehensive review in this journal addressing the topic of promoting successful cognitive aging, making this a good time to take stock of the field. Because there have been limited large-scale, randomized controlled trials, especially following individuals from middle age to late life, some experts have questioned whether recommendations can be legitimately offered about reducing the risk of cognitive decline and dementia. Despite uncertainties, clinicians often need to at least make provisional recommendations to patients based on the highest quality data available. Converging lines of evidence from epidemiological/cohort studies, animal/basic science studies, human proof-of-concept studies, and human intervention studies can provide guidance, highlighting strategies for enhancing cognitive reserve and preventing loss of cognitive capacity. Many of the suggestions made in 2010 have been supported by additional research. Importantly, there is a growing consensus among major health organizations about recommendations to mitigate cognitive decline and promote healthy cognitive aging. Regular physical activity and treatment of cardiovascular risk factors have been supported by all of these organizations. Most organizations have also embraced cognitively stimulating activities, a heart-healthy diet, smoking cessation, and countering metabolic syndrome. Other behaviors like regular social engagement, limiting alcohol use, stress management, getting adequate sleep, avoiding anticholinergic medications, addressing sensory deficits, and protecting the brain against physical and toxic damage also have been endorsed, although less consistently. In this update, we review the evidence for each of these recommendations and offer practical advice about behavior-change techniques to help patients adopt brain-healthy behaviors.
- 21 April 2021
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 81 (3) , 871-920
Open AccessPromoting Successful Cognitive Aging: A Ten-Year Update
A decade has passed since we published a comprehensive review in this journal addressing the topic of promoting successful cognitive aging, making this a good time to take stock of the field. Because there have been limited large-scale, randomized controlled trials, especially following individuals from middle age to late life, some experts have questioned whether recommendations can be legitimately offered about reducing the risk of cognitive decline and dementia. Despite uncertainties, clinicians often need to at least make provisional recommendations to patients based on the highest quality data available. Converging lines of evidence from epidemiological/cohort studies, animal/basic science studies, human proof-of-concept studies, and human intervention studies can provide guidance, highlighting strategies for enhancing cognitive reserve and preventing loss of cognitive capacity. Many of the suggestions made in 2010 have been supported by additional research. Importantly, there is a growing consensus among major health organizations about recommendations to mitigate cognitive decline and promote healthy cognitive aging. Regular physical activity and treatment of cardiovascular risk factors have been supported by all of these organizations. Most organizations have also embraced cognitively stimulating activities, a heart-healthy diet, smoking cessation, and countering metabolic syndrome. Other behaviors like regular social engagement, limiting alcohol use, stress management, getting adequate sleep, avoiding anticholinergic medications, addressing sensory deficits, and protecting the brain against physical and toxic damage also have been endorsed, although less consistently. In this update, we review the evidence for each of these recommendations and offer practical advice about behavior-change techniques to help patients adopt brain-healthy behaviors.
- Open Access
- 1 April 2021
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 11 (2) , 167-174
Cognitive Impairment in Aging Physicians
Aging physicians are at a higher risk of cognitive impairment, undermining patient safety and unraveling physicians9 careers. Neurologists, occupational health physicians, and psychiatrists will participate in both health system policy decisions and individual patient evaluations. We address cognitive impairment in aging physicians and attendant risks and benefits. If significant cognitive impairment is found after an appropriate evaluation, precautions to confidentially support physicians9 practicing safely for as long as possible should be instituted. Understanding that there is heterogeneity and variability in the course of cognitive disorders is crucial to supporting cognitively impaired, practicing physicians. Physicians who are no longer able to practice clinically have other meaningful options.
- 1 April 2021
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 11 (2) , 167-174
Open AccessCognitive Impairment in Aging Physicians
Aging physicians are at a higher risk of cognitive impairment, undermining patient safety and unraveling physicians9 careers. Neurologists, occupational health physicians, and psychiatrists will participate in both health system policy decisions and individual patient evaluations. We address cognitive impairment in aging physicians and attendant risks and benefits. If significant cognitive impairment is found after an appropriate evaluation, precautions to confidentially support physicians9 practicing safely for as long as possible should be instituted. Understanding that there is heterogeneity and variability in the course of cognitive disorders is crucial to supporting cognitively impaired, practicing physicians. Physicians who are no longer able to practice clinically have other meaningful options.
- 17 February 2021
- Published by Wiley in Journal of Hospital Medicine
- Vol. 16 (3) , 184
Rebuttal: Accounting for the Community's Reciprocal Obligations to Healthcare Workers During a Pandemic
Corresponding Author: Kirk R Daffner, MD; Email: kdaffner@bwh.harvard.edu; Telephone: 617-732-8060; Twitter: @krdaffner.
- 17 February 2021
- Published by Wiley in Journal of Hospital Medicine
- Vol. 16 (3) , 184
Rebuttal: Accounting for the Community's Reciprocal Obligations to Healthcare Workers During a Pandemic
Corresponding Author: Kirk R Daffner, MD; Email: kdaffner@bwh.harvard.edu; Telephone: 617-732-8060; Twitter: @krdaffner.
- 17 February 2021
- Published by Wiley in Journal of Hospital Medicine
- Vol. 16 (3) , 180-181
Point: Healthcare Providers Should Receive Treatment Priority During a Pandemic
Corresponding Author: Kirk R Daffner, MD; Email: kdaffner@bwh.harvard.edu; Telephone: 617-732-8060; Twitter: @krdaffner.
- 17 February 2021
- Published by Wiley in Journal of Hospital Medicine
- Vol. 16 (3) , 180-181
Point: Healthcare Providers Should Receive Treatment Priority During a Pandemic
Corresponding Author: Kirk R Daffner, MD; Email: kdaffner@bwh.harvard.edu; Telephone: 617-732-8060; Twitter: @krdaffner.